Outcomes of transsphenoidal surgery in dopamine agonist-resistant prolactinomas: a retrospective study.

Purpose: Dopamine agonists (DA) comprise first-line treatment for prolactinomas. However, some patients show no response to DA and are considered resistant. In this study, we retrospectively analyzed the outcomes of DA-resistant prolactinoma patients after transsphenoidal surgery (TSS).